Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC14411 Apoptozole

    Apoptosis Activator VII

    An inhibitor of Hsp70
  3. GC14016 Sulforaphane

    萝卜硫素

    萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。

  4. GC16625 CDDO-TFEA

    CDDO-Trifluoethyl Amide,RTA 404,TP-500

    A synthetic triterpenoid with potent anticancer and neuroprotective activity
  5. GC17119 8-Prenylnaringenin

    8-异戊烯基柚皮素

    A phytoestrogen
  6. GC12639 NS3694

    Apoptosis Inhibitor II

    An inhibitor of apoptosome formation and caspase activation
  7. GC16375 (±)-Jasmonic Acid methyl ester

    甲基茉莉酮酸酯,(±)-Methyl Jasmonate

    A plant growth regulator
  8. GC11988 15-acetoxy Scirpenol

    15-乙酰蛇形菌素

    A trichothecene mycotoxin
  9. GC10661 Destruxin B

    黑僵菌素 B

    An insecticidal mycotoxin
  10. GC15225 COTI-2 An activator of mutant forms of p53
  11. GC11989 Nortriptyline (hydrochloride)

    盐酸去甲替林; Desmethylamitriptyline hydrochloride; Desitriptilina hydrochloride

    A tricyclic antidepressant
  12. GC13194 RPI-1 A RET kinase inhibitor
  13. GC14355 CRT5

    CRT0066051

    A pan PKD inhibitor
  14. GC10022 SP 141

    6-甲氧基-1-(萘-1-基)-9H-吡啶并[3,4-B]吲哚,AGN-PC-0D106I

    An inhibitor of MDM2
  15. GC17649 Mebendazole

    甲苯咪唑

    A broad-spectrum anthelmintic that inhibits microtubules
  16. GC15812 p-nitro-Pifithrin-α

    p-nitro-PFT-α

    A cell-permeable inactivator of p53
  17. GC16661 Citrinin

    桔霉素; NSC 186

    Citrinin是一种具有多种生物活性的霉菌毒素,由青霉属、曲霉属和红曲霉属的几种真菌菌株产生。
  18. GC16409 Oligomycin B

    寡霉素 B

    A nonselective inhibitor of the mitochondrial F1FO ATP synthase
  19. GC10040 Arylquin 1 A Par-4 secretagogue
  20. GC16362 AD57 (hydrochloride) A polypharmacological cancer therapeutic
  21. GC15880 Penicillic Acid

    青霉酸,NSC 402844

    A mycotoxin that inhibits quorum sensing
  22. GC16350 Actinonin

    放线酰胺素,(-)-Actinonin,Ro 06-1467

    An aminopeptidase inhibitor
  23. GC16823 Enniatin Complex

    恩镰孢菌素复合物

    A complex mixture of ionophores
  24. GC14050 MPI-0441138

    EP128265

    A potent inducer of apoptosis and growth inhibition
  25. GC10601 Ubiquitin Isopeptidase Inhibitor I

    NSC 144303

    An activator of caspases
  26. GC12545 2-HBA

    Bis(2-hydroxybenzylidene)acetone

    An indirect inhibitor of Keap1-Nrf2 interactions
  27. GC15394 CBL0137 (hydrochloride)

    CBL0137盐酸盐,CBLC137,Curaxin 137

    An activator of p53 and inhibitor of NF-κB
  28. GC14634 CBL0137

    CBLC137,Curaxin 137

    An activator of p53 and inhibitor of NF-κB
  29. GC17287 Iberin

    3-甲基亚磺酰丙基异硫氰酸酯,NSC 321801

    A natural isothiocyanate

  30. GC11659 R-7050

    TNF-α Antagonist III

    R-7050 是一种新型细胞渗透性三唑并喹喔啉化合物,可选择性抑制 TNF-α;诱导细胞信号传导。
  31. GC15710 ML-354

    VU0099704

    A PAR4 antagonist
  32. GC12124 Selonsertib (GS-4997)

    GS-4997

    An ASK1 inhibitor
  33. GC17023 HLCL-61 A PRMT5 inhibitor
  34. GC13630 MK-4101

    5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑

    A Smoothened receptor antagonist
  35. GC15946 ReACp53 ReACp53 可以抑制 p53 淀粉样蛋白的形成并挽救癌细胞系中的 p53 功能。
  36. GC15573 GSK481 A selective inhibitor of RIP1
  37. GC16258 PD-1/PD-L1 Inhibitor 3 A PD-1/PD-L1 interaction inhibitor
  38. GC16151 NSC348884

    N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺

    A nucleophosmin inhibitor
  39. GC15282 LOXO-101 (Larotrectinib) sulfate

    (3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐,LOXO-101 sulfate; ARRY-470 sulfate

    A pan-Trk inhibitor
  40. GC15142 PD-1/PD-L1 inhibitor 1 (BMS-1)

    BMS-1

    PD-1/PD-L1 inhibitor 1 是一种 PD-1/PD-L1 相互作用抑制剂,IC50 值介于 6 和 100 nM . PD-1/PD-L1 调节细胞信号通路和表观遗传修饰,从而抑制 T 细胞和 B 细胞的增殖和效应子功能。
  41. GC13648 CC-223

    CC-223; ATG-008

    A potent, selective inhibitor of mTOR
  42. GC16039 LJH685

    2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚

    An inhibitor of RSKs
  43. GC11837 MI-136 A menin-MLL inhibitor
  44. GC17513 A-1331852 A Bcl-xL inhibitor
  45. GC17512 A-1155463

    醋酸艾塞那肽

    A Bcl-xL inhibitor
  46. GC12962 Isatin

    靛红,Indoline-2,3-dione

    Isatin (Indoline-2,3-dione) 是一种有效的单胺氧化酶 (MAO) 抑制剂,IC50 为 3 μM。
  47. GC16517 Eugenol

    丁香酚

    丁香酚是一种存在于丁香中的精油,具有抗菌、驱虫和抗氧化活性。
  48. GC10855 Etretinate

    依曲替酯; Ro 10-9359

    A second-generation retinoid
  49. GC11935 Escin

    七叶皂苷

    七叶皂苷是一种从七叶树 (Aesculus hippocastanum) 种子中分离出来的三萜皂苷的天然化合物,可用作血管保护性抗炎、抗水肿和抗伤害剂。
  50. GC14500 CPI-1189

    N-叔丁基-4-乙酰氨基苯甲酰胺

    A benzamide
  51. GC14503 IC261

    SU5607

    A reversible inhibitor of CK1

Items 1951 to 2000 of 2733 total

per page

Set Descending Direction